In the double-blind portion of Vibrance-1, alixorexton improved wakefulness while eliciting broad benefits in patient-reported outcomes.

administrator
Related Articles
Final Thoughts on Shingles Management
- September 9, 2025
Challenges in Shingles Prevention
- September 9, 2025